Your browser doesn't support javascript.
loading
The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting.
Salati, Massimiliano; Caputo, Francesco; Baldessari, Cinzia; Carotenuto, Pietro; Messina, Marco; Caramaschi, Stefania; Dominici, Massimo; Bonetti, Luca Reggiani.
Affiliation
  • Salati M; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Caputo F; PhD Program Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Baldessari C; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Carotenuto P; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Messina M; Department of Genomics, Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
  • Caramaschi S; Department of Oncology, Fondazione Istituto G. Giglio, Cefalu, Italy.
  • Dominici M; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia - AOU Policlinico of Modena, Modena, Italy.
  • Bonetti LR; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
Cancer Manag Res ; 13: 7747-7757, 2021.
Article in En | MEDLINE | ID: mdl-34675670
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancer Manag Res Year: 2021 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancer Manag Res Year: 2021 Type: Article Affiliation country: Italy